Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 1
2005 3
2006 1
2007 3
2008 1
2009 3
2010 5
2011 5
2012 4
2013 5
2014 4
2015 3
2016 1
2017 1
2018 2
2019 5
2020 5
2021 2
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Colorectal adenosquamous carcinoma: genomic profiling of a rare histotype of colorectal cancer.
Angerilli V, Parente P, Businello G, Vanoli A, Paudice M, Perrone G, Munari G, Govoni I, Neri G, Rebellato E, Parrella P, Grillo F, Mastracci L, Fassan M. Angerilli V, et al. Among authors: parrella p. Virchows Arch. 2023 May;482(5):879-885. doi: 10.1007/s00428-023-03517-6. Epub 2023 Feb 15. Virchows Arch. 2023. PMID: 36790480 Free PMC article.
Androgen receptor in breast cancer: The "5W" questions.
Ravaioli S, Maltoni R, Pasculli B, Parrella P, Giudetti AM, Vergara D, Tumedei MM, Pirini F, Bravaccini S. Ravaioli S, et al. Among authors: parrella p. Front Endocrinol (Lausanne). 2022 Aug 30;13:977331. doi: 10.3389/fendo.2022.977331. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36111296 Free PMC article. Review.
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.
Klec C, Knutsen E, Schwarzenbacher D, Jonas K, Pasculli B, Heitzer E, Rinner B, Krajina K, Prinz F, Gottschalk B, Ulz P, Deutsch A, Prokesch A, Jahn SW, Lellahi SM, Perander M, Barbano R, Graier WF, Parrella P, Calin GA, Pichler M. Klec C, et al. Among authors: parrella p. Cell Mol Life Sci. 2022 Jul 1;79(7):391. doi: 10.1007/s00018-022-04402-2. Cell Mol Life Sci. 2022. PMID: 35776213 Free PMC article.
Combined analysis of miR-200 family and its significance for breast cancer.
Fontana A, Barbano R, Dama E, Pasculli B, Rendina M, Morritti MG, Melocchi V, Castelvetere M, Valori VM, Ravaioli S, Bravaccini S, Ciuffreda L, Graziano P, Maiello E, Copetti M, Fazio VM, Esteller M, Bianchi F, Parrella P. Fontana A, et al. Among authors: parrella p. Sci Rep. 2021 Feb 3;11(1):2980. doi: 10.1038/s41598-021-82286-1. Sci Rep. 2021. PMID: 33536459 Free PMC article.
BRAFV600E mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies.
Trivieri N, Pracella R, Cariglia MG, Panebianco C, Parrella P, Visioli A, Giani F, Soriano AA, Barile C, Canistro G, Latiano TP, Dimitri L, Bazzocchi F, Cassano D, Vescovi AL, Pazienza V, Binda E. Trivieri N, et al. Among authors: parrella p. J Exp Clin Cancer Res. 2020 Dec 14;39(1):285. doi: 10.1186/s13046-020-01801-w. J Exp Clin Cancer Res. 2020. PMID: 33317591 Free PMC article.
Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors.
Pasculli B, Barbano R, Fontana A, Biagini T, Di Viesti MP, Rendina M, Valori VM, Morritti M, Bravaccini S, Ravaioli S, Maiello E, Graziano P, Murgo R, Copetti M, Mazza T, Fazio VM, Esteller M, Parrella P. Pasculli B, et al. Among authors: parrella p. Front Oncol. 2020 Aug 12;10:1415. doi: 10.3389/fonc.2020.01415. eCollection 2020. Front Oncol. 2020. PMID: 32903519 Free PMC article.
61 results